| Usama Bin Nasir, MD | |
|
711 Cottage Grove Rd, Bloomfield, CT 06002-3060 | |
| (860) 242-8756 | |
| Not Available |
| Full Name | Usama Bin Nasir |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 9 Years |
| Location | 711 Cottage Grove Rd, Bloomfield, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134570633 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hartford Hospital | Hartford, CT | Hospital |
| Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
With the evolving changes in the delivery of healthcare to children worldwide, which frequently include long-distance travel and lodging for specialized medical treatments, the Society for Healthcare Epidemiology of America partnered with Ronald McDonald House Charities to release the first-ever infection prevention and control guidelines for "home away from home" pediatric residential facilities to help prevent the spread of infectious pathogens among vulnerable pediatric populations.
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
A $2 million grant from the National Institutes of Health will help University of Illinois at Chicago researchers study how herpesviruses, and their underlying molecular mechanisms, contribute to increased inflammation in oral diseases, like periodontitis
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function.
› Verified 3 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
With the evolving changes in the delivery of healthcare to children worldwide, which frequently include long-distance travel and lodging for specialized medical treatments, the Society for Healthcare Epidemiology of America partnered with Ronald McDonald House Charities to release the first-ever infection prevention and control guidelines for "home away from home" pediatric residential facilities to help prevent the spread of infectious pathogens among vulnerable pediatric populations.
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
A $2 million grant from the National Institutes of Health will help University of Illinois at Chicago researchers study how herpesviruses, and their underlying molecular mechanisms, contribute to increased inflammation in oral diseases, like periodontitis
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Usama Bin Nasir, MD 711 Cottage Grove Rd, Bloomfield, CT 06002-3060 Ph: (860) 242-8756 | Usama Bin Nasir, MD 711 Cottage Grove Rd, Bloomfield, CT 06002-3060 Ph: (860) 242-8756 |
News Archive
With the evolving changes in the delivery of healthcare to children worldwide, which frequently include long-distance travel and lodging for specialized medical treatments, the Society for Healthcare Epidemiology of America partnered with Ronald McDonald House Charities to release the first-ever infection prevention and control guidelines for "home away from home" pediatric residential facilities to help prevent the spread of infectious pathogens among vulnerable pediatric populations.
In recent years, researchers have realized that many products, including pharmaceuticals, have ended up where they're not supposed to be - in our drinking water. But now scientists have developed a way to make drugs that break down into harmless compounds before they contaminate our taps.
A $2 million grant from the National Institutes of Health will help University of Illinois at Chicago researchers study how herpesviruses, and their underlying molecular mechanisms, contribute to increased inflammation in oral diseases, like periodontitis
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced that the first patient has been enrolled in an open-label phase III study to investigate the efficacy, safety, and pharmacokinetics of the sustained release triptorelin pamoate 22.5 mg 6-month-formulation in children with central precocious puberty (CPP), a rare disease.
New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function.
› Verified 3 days ago
Richard Siahaan, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 421 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-0034 Fax: 860-242-3301 | |
Tracy E Patel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-242-3052 | |
Dr. Roy A Kellerman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr Ste 201, Bloomfield, CT 06002 Phone: 860-243-5569 Fax: 860-243-2622 | |
Arthur Bernard Landry Jr., M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-769-5009 | |
Dr. Linda Rickman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 852 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-714-5895 Fax: 860-714-5417 | |
Oksana Kloyzner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Cottage Grove Rd, Suite F, Bloomfield, CT 06002 Phone: 860-242-4000 Fax: 860-243-8286 |